GlassScriptPhysician profile
Arsalan Shahzad
NPI 1518071620
$22,464.49
in general payments reported to CMS, 2019-2025
35 companies · $3,969 in 2025
The $3,969 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,272 · 2020: $875 · 2021: $1,633 · 2022: $6,879 · 2023: $4,475 · 2024: $1,361 · 2025: $3,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,415 · Travel and Lodging: $4,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,415.07 |
| Travel and Lodging | $4,390.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,275.57 | 2019-2025 | Optis, Aveir, Confirm Rx |
| Medtronic, INC. | $3,285.90 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Hawkone |
| Boston Scientific Corporation | $2,072.67 | 2021-2025 | Versacross Access Solution, Watchman Flx, Avvigo Guidance System |
| Terumo Medical Corporation | $1,367.70 | 2025 | Glidewire, R2p Misago |
| Endologix LLC | $1,312.51 | 2019-2023 | Alto Abdominal Stent Graft System |
| Abiomed | $1,188.41 | 2019-2025 | Impella |
| Philips North America LLC | $618.93 | 2019-2025 | (Bh4) Igt Devices Undivided, Azurion 5 M20 |
| Impulse Dynamics (USA) INC. | $557.69 | 2022-2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $446.00 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $343.59 | 2019-2025 | |
| Amgen INC. | $209.03 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $204.39 | 2019-2025 | Camzyos, Eliquis |
| Stryker Corporation | $171.50 | 2025 | Flowtriever |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.66 | 2019-2024 | Lifevest |
| Heartflow, INC. | $118.14 | 2019-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $113.90 | 2019 | |
| Acist Medical Systems, INC. | $108.02 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $105.68 | 2019-2023 | Farxiga |
| Biosense Webster, INC. | $103.26 | 2023-2024 | Carto 3 |
| Esperion Therapeutics, INC. | $94.79 | 2021-2023 | Nexletol |
| Amarin Pharma, INC. | $93.17 | 2019-2022 | |
| Pfizer INC. | $77.18 | 2019-2025 | |
| Edwards Lifesciences Corporation | $63.01 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $62.57 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $60.90 | 2025 | Uptravi, Opsumit |
| Bard Peripheral Vascular, INC. | $54.41 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.47 | 2019-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $36.27 | 2019-2022 | |
| Shockwave Medical, INC | $33.02 | 2025 | |
| Cook Medical LLC | $21.96 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.50 | 2019 | |
| Agepha Pharma Fz LLC | $20.10 | 2025 | Lodoco |
| Elutia, INC. | $19.47 | 2020 | |
| Cvrx, INC. | $18.46 | 2024 | Barostim Neo System |
| Angiodynamics, INC. | $15.66 | 2023 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arsalan Shahzad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.